imipenem, anhydrous has been researched along with Bronchial Pneumonia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, W; Harris, G; Kanzaki, G; Kuo Lee, R; Lam, CK; Patel, GB; Xu, HH | 1 |
Matsumoto, S; Narita, M; Shibata, M; Togashi, T; Tomizawa, K | 1 |
Bentzon, MW; Høiby, N; Jensen, T; Koch, C; Pedersen, SS; Pressler, T; Rosdahl, VT | 1 |
3 other study(ies) available for imipenem, anhydrous and Bronchial Pneumonia
Article | Year |
---|---|
A mouse model of Acinetobacter baumannii-associated pneumonia using a clinically isolated hypervirulent strain.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacteremia; Bacterial Vaccines; Body Weight; Bronchopneumonia; Disease Models, Animal; Female; Imipenem; Immunization; Lung; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microbial Sensitivity Tests; Minocycline; Pneumonia, Bacterial; Reproducibility of Results; Tigecycline; Time Factors | 2013 |
Steroid therapy for bronchopneumonia in chronic granulomatous disease.
Topics: Adolescent; Bronchopneumonia; Cefazolin; Drug Therapy, Combination; Granulomatous Disease, Chronic; Humans; Imipenem; Male; Prednisolone | 1991 |
Combined imipenem/cilastatin and tobramycin therapy of multiresistant Pseudomonas aeruginosa in cystic fibrosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bronchopneumonia; Child; Chronic Disease; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Cystic Fibrosis; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Female; Humans; Imipenem; Kinetics; Male; Microbial Sensitivity Tests; Penicillin Resistance; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Thienamycins; Tobramycin | 1987 |